查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1467929

2024-2032 年气雾剂输送设备市场报告（按产品、应用（气喘、慢性阻塞性肺病、囊性纤维化、非呼吸系统疾病）、配销通路和地区）

Aerosol Delivery Devices Market Report by Product, Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Non-Respiratory Diseases), Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球气雾剂输送装置市场规模达到 471 亿美元。

气雾剂输送装置用于药物传递和治疗呼吸系统疾病，例如气喘、阻塞性肺病、囊性纤维化、肺动脉高压、感染性肺病。它们降低了剂量需求，减少了全身不良反应并提高了患者自我用药的能力。一些常用的气雾剂输送装置是加压定量吸入器、雾化器和带阀的保持器室。目前，由于新型大分子药物的出现，智慧气雾剂给药装置被用于非呼吸系统疾病，如糖尿病、镇痛、甲状腺疾病和遗传性疾病。

气雾剂输送装置市场趋势：

导致患者急性呼吸道感染的冠状病毒疾病（COVID-19）在全球爆发，是推动气雾剂输送设备需求的关键因素之一。这些设备有助于在家中和医疗机构中治疗阻塞性气道疾病。除此之外，由于空气污染水平、过敏原和职业风险的飙升，慢性呼吸道感染的盛行率不断上升，以及吸烟和饮酒的人数不断增加，正在推动市场的成长。此外，老年人口数量大幅增加，更容易患上严重的健康疾病，这对方便且经济的便携式吸入装置的需求产生了积极影响。除此之外，市场参与者正在开发新型气雾剂输送装置，帮助治疗肺部慢性发炎和感染，并改善囊性纤维化 (CF) 患者的气道清除率。此外，他们还透过电子商务管道提供迷你超音波雾化器和吸入器，这些雾化器和吸入器具有自动记忆功能，易于在旅行时使用。这与个人化药物治疗的需求不断增长以及越来越多地使用线上管道购买医疗用品相结合，正在推动市场的发展。

本报告回答的关键问题

  • 2023 年全球气雾剂输送设备市场规模有多大？
  • 2024-2032年全球气雾剂输送装置市场的预期成长率是多少？
  • 推动全球气雾剂输送设备市场的关键因素是什么？
  • COVID-19 对全球气雾剂输送设备市场有何影响？
  • 基于产品的全球气雾剂输送装置市场的细分如何？
  • 根据配销通路，全球气雾剂输送装置市场的细分如何？
  • 全球气雾剂输送设备市场的关键区域有哪些？
  • 谁是全球气雾剂输送设备市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球气雾剂输送设备市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 干粉吸入器
    • 市场走向
    • 关键环节
      • 单剂量吸入器
      • 多剂量吸入器
    • 市场预测
  • 定量吸入器
    • 市场走向
    • 关键环节
      • 传统加压吸入器
      • 软雾吸入器
    • 市场预测
  • 雾化器
    • 市场走向
    • 关键环节
      • 喷射雾化器
      • 超音波雾化器
      • 振动网雾化器
    • 市场预测

第 7 章：市场区隔：按应用

  • 气喘
    • 市场走向
    • 市场预测
  • 慢性阻塞性肺病（COPD）
    • 市场走向
    • 市场预测
  • 囊肿纤维化
    • 市场走向
    • 市场预测
  • 非呼吸系统疾病
    • 市场走向
    • 关键环节
      • 糖尿病
      • 镇痛
      • 帕金森氏症
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 零售药局
    • 市场走向
    • 市场预测
  • 医院药房
    • 市场走向
    • 市场预测
  • 网上商店
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • Aerogen
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Koninklijke Philips NV
    • Merck & Co. Inc.
    • Metall Zug AG
    • Recipharm AB (publ)
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group plc
Product Code: SR112024A4892

The global aerosol delivery devices market size reached US$ 47.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 73.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.

Aerosol delivery devices are used in drug delivery and treating respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis, pulmonary arterial hypertension, infectious pulmonary. They lower dosage requirements, reduce systemic adverse effects and improve the ability of patients to self-administer medication. Some of the commonly available aerosol delivery devices are pressurized metered-dose inhalers, nebulizers, and valved holder chambers. At present, smart aerosol drug delivery devices are used in non-respiratory conditions, such as diabetes, analgesia, thyroid disorders, and genetic diseases, due to the advent of novel macromolecular medications.

Aerosol Delivery Devices Market Trends:

The global outbreak of the coronavirus disease (COVID-19) that leads to acute respiratory infections among patients represents one of the key factors driving the need for aerosol delivery devices. These devices assist in treating obstructive airway diseases at home and in healthcare settings. Apart from this, the rising prevalence of chronic respiratory infections due to surging air pollution levels, allergens and occupational risks, and the increasing number of individuals who smoke tobacco and drink is propelling the market growth. Moreover, a considerable rise in the geriatric population, which is more vulnerable to developing serious health illnesses, is positively influencing the demand for portable inhalation devices that are convenient and economical. Besides this, market players are developing novel aerosol delivery devices that help treat chronic inflammation and infection in the lungs and improve airway clearance in patients with cystic fibrosis (CF). Furthermore, they are offering mini ultrasonic nebulizers and inhalers through e-commerce channels that have automatic memory and are easy to use while traveling. This, in confluence with the escalating demand for personalized drug therapy and the increasing use of online channels for purchasing medical supplies, is driving the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global aerosol delivery devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and distribution channel.

Breakup by Product:

Dry Powder Inhalers

Single Dose Inhalers

Multi Dose Inhalers

Metered Dose Inhalers

Conventional Pressurized Inhalers

Soft Mist Inhalers

Nebulizers

Jet Nebulizers

Ultrasonic Wave Nebulizers

Vibrating Mesh Nebulizers

Breakup by Application:

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis

Non-Respiratory Diseases

Diabetes

Analgesia

Parkinson's Disease

Breakup by Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Stores

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report

  • 1. What was the size of the global aerosol delivery devices market in 2023?
  • 2. What is the expected growth rate of the global aerosol delivery devices market during 2024-2032?
  • 3. What are the key factors driving the global aerosol delivery devices market?
  • 4. What has been the impact of COVID-19 on the global aerosol delivery devices market?
  • 5. What is the breakup of the global aerosol delivery devices market based on the product?
  • 6. What is the breakup of the global aerosol delivery devices market based on the distribution channel?
  • 7. What are the key regions in the global aerosol delivery devices market?
  • 8. Who are the key players/companies in the global aerosol delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Aerosol Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Dry Powder Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Single Dose Inhalers
      • 6.1.2.2 Multi Dose Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Metered Dose Inhalers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Conventional Pressurized Inhalers
      • 6.2.2.2 Soft Mist Inhalers
    • 6.2.3 Market Forecast
  • 6.3 Nebulizers
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Jet Nebulizers
      • 6.3.2.2 Ultrasonic Wave Nebulizers
      • 6.3.2.3 Vibrating Mesh Nebulizers
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cystic Fibrosis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Non-Respiratory Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Key Segments
      • 7.4.2.1 Diabetes
      • 7.4.2.2 Analgesia
      • 7.4.2.3 Parkinson's Disease
    • 7.4.3 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aerogen
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 GlaxoSmithKline plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Koninklijke Philips N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Metall Zug AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Recipharm AB (publ)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vectura Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Aerosol Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Aerosol Delivery Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Aerosol Delivery Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Aerosol Delivery Devices Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Aerosol Delivery Devices Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Aerosol Delivery Devices Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Aerosol Delivery Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Aerosol Delivery Devices (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Aerosol Delivery Devices (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Aerosol Delivery Devices (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Aerosol Delivery Devices (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Aerosol Delivery Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Aerosol Delivery Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Aerosol Delivery Devices (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Aerosol Delivery Devices (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Aerosol Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Aerosol Delivery Devices Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Aerosol Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Aerosol Delivery Devices Industry: SWOT Analysis
  • Figure 78: Global: Aerosol Delivery Devices Industry: Value Chain Analysis
  • Figure 79: Global: Aerosol Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Aerosol Delivery Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Aerosol Delivery Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Aerosol Delivery Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Aerosol Delivery Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Aerosol Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Aerosol Delivery Devices Market: Competitive Structure
  • Table 7: Global: Aerosol Delivery Devices Market: Key Players